Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases (Q36671522)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 3, 2003

edit

Language	Label	Description	Also known as
English	Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases	scientific article published on November 3, 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

title

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

main subject

phase II clinical trial

0 references

oncology

1 reference

stated in

Crossref

DOI

10.1038/SJ.BJC.6601320

reference URL

https://api.crossref.org/works/10.1038/SJ.BJC.6601320

retrieved

26 March 2024

author

Jürgen Bauer

series ordinal

3

object named as

J. Bauer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

Thomas Kurt Eigentler

series ordinal

6

object named as

T. K. Eigentler

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

Claus Garbe

series ordinal

9

object named as

C. Garbe

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

author name string

P. Radny

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

U. M. Caroli

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

T. Paul

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

C. Schlegel

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

B. Weide

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

M. Schwarz

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

3 November 2003

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

14583759

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583759

retrieved

26 March 2024

full work available at URL

https://www.nature.com/articles/6601320.pdf

file format

Portable Document Format

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

https://europepmc.org/articles/PMC2394422

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

https://europepmc.org/articles/PMC2394422?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14583759

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583759

retrieved

26 March 2024

http://www.nature.com/articles/6601320.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1038/SJ.BJC.6601320

reference URL

https://api.crossref.org/works/10.1038/SJ.BJC.6601320

retrieved

26 March 2024

http://www.nature.com/articles/6601320

1 reference

stated in

Crossref

DOI

10.1038/SJ.BJC.6601320

reference URL

https://api.crossref.org/works/10.1038/SJ.BJC.6601320

retrieved

26 March 2024

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

volume

89

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

issue

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

page(s)

1620-1626

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

cites work

Advances in specific immunotherapy of malignant melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Melanoma. A multidisciplinary approach for the general surgeon

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Therapeutic advances in melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

30 September 2017

Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

28 June 2018

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

28 June 2018

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

28 June 2018

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

28 June 2018

Bleomycin-mediated electrochemotherapy of metastatic melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

28 June 2018

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

20 September 2018

Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394422

retrieved

20 September 2018

Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional interferon treatment of lentigo maligna

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regressive effect of intralesional injection of a moderate dose of recombinant interleukin-2 on carcinoma erysipeloides from gastric carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional interferon-alpha therapy in advanced malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local treatment of cutaneous and subcutaneous metastatic malignant melanoma with fotemustine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional therapy of melanoma metastases with recombinant interferon-beta

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of malignant haemangioendothelioma showing response to interleukin 2 therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Peritumoral administered IL-2-induced tumor regression in melanoma. Pilot study]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/14583759

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6601320

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

Dimensions Publication ID

1002850974

0 references

PMC publication ID

2394422

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

PubMed publication ID

14583759

1 reference

stated in

Europe PubMed Central

PMC publication ID

2394422

retrieved

15 August 2017

ResearchGate publication ID

9035687

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36671522&oldid=2199165698"